ELANE and chronic obstructive pulmonary disease: Separate, ongoing studies are evaluating the inhibition of NE and MMP‐9 (including active MMP‐9 and proMMP‐9) as a novel means of increasing treatment effectiveness in COPD 11, 12, 17, 36, 37.